RALLYBIO CORPORATION Current Assets
RALLYBIO CORPORATION (RLYB) had Current Assets of $97.25 million as of 2026-06-30, per its S-4/A filed 2026-08-26.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-26
- 2026-06-30: Assets, Current $97.25M.
- 2026-03-31: Assets, Current $53.49M.
- 2025-12-31: Assets, Current $61.25M.
- 2025-09-30: Assets, Current $66.63M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $97.25M S-4/A · filed 2026-08-26 |
| 2026-03-31 | $53.49M S-4 · filed 2026-07-15 |
| 2025-12-31 | $61.25M S-4/A · filed 2026-08-26 |
| 2025-09-30 | $66.63M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $50.27M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $57.38M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $67.84M S-4/A · filed 2026-08-26 |
| 2024-09-30 | $78.23M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $91.44M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $98.55M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $114.79M 10-K · filed 2025-03-13 |
| 2023-09-30 | $132.42M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $146.83M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $161.28M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $179.50M 10-K · filed 2024-03-12 |
| 2022-09-30 | $142.43M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $154.30M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $167.78M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $180.87M 10-K · filed 2023-03-06 |
| 2021-09-30 | $192.39M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $118.43M 10-Q · filed 2021-09-09 |
| 2020-12-31 | $141.26M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |